NovAccess Global, Inc.- MoneyTV with Donald Baillargeon from xsnx Watch Video
Preview(s): Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Your browser does not support playing the video.Please download the video!
Description: On MoneyTV with Donald Baillargeon, NovAccess Global, Inc. (OTCPINK: XSNX) CEO Dr. Dwain Irvin said StemVax is submitting an IND application for FDA approval to begin a Phase IIa clinical trial.